First Time Loading...

Castlight Health Inc
NYSE:CSLT

Watchlist Manager
Castlight Health Inc Logo
Castlight Health Inc
NYSE:CSLT
Watchlist
Price: 2.05 USD Market Closed
Updated: May 1, 2024
Section:
 

Relative Value

CSLT price has not been updated for more than 11 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of CSLT.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CSLT Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
vs Industry
46
Median 3Y
2.3
Median 5Y
2.3
Industry
2.4
Forward
2.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-38.6
Median 5Y
-27.8
Industry
23.2
More Details
15.8
P/OCF
P/OCF
Price to OCF
15.8
vs History
vs Industry
27
Median 3Y
15.8
Median 5Y
11.9
Industry
15.5
More Details
18.8
P/FCFE
P/FCFE
Price to FCFE
18.8
vs History
vs Industry
26
Median 3Y
16.6
Median 5Y
12.4
Industry
23.5
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
vs Industry
34
Median 3Y
2.6
Median 5Y
2.4
Industry
2.2
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
vs Industry
51
Median 3Y
1.9
Median 5Y
1.9
Industry
2.5
Forward
1.9
More Details
2.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.9
vs History
vs Industry
61
Median 3Y
2.9
Median 5Y
2.9
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-118.6
Median 5Y
-77.5
Industry
12.5
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-30.3
Median 5Y
-20.1
Industry
17.2
More Details
12.7
EV/OCF
EV/OCF
Enterprise Value to OCF
12.7
vs History
vs Industry
33
Median 3Y
12.7
Median 5Y
8.8
Industry
15.1
More Details
13.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
13.2
vs History
vs Industry
31
Median 3Y
13.2
Median 5Y
9.1
Industry
19.7
More Details
2.8
EV/IC
EV/IC
Enterprise Value to IC
2.8
vs History
vs Industry
29
Median 3Y
2.8
Median 5Y
2.4
Industry
2
More Details

Multiples Across Competitors

CSLT Competitors Multiples
Castlight Health Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Castlight Health Inc
NYSE:CSLT
332.3m USD 2.3 -38.5 -118.6 -30.3
US
Veeva Systems Inc
NYSE:VEEV
32.1B USD 13.6 61.1 60.9 65.5
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.4B AUD 78.1 163.7 112.5 112.5
US
Inspire Medical Systems Inc
NYSE:INSP
7.2B USD 11.5 -340.1 -179.9 -167.2
JP
M3 Inc
TSE:2413
1.1T JPY 4.8 24.2 12.6 14.2
US
Doximity Inc
NYSE:DOCS
4.5B USD 9.7 33 22.1 23.5
SE
Sectra AB
STO:SECT B
42.2B SEK 25.8 99.5 -65.5 -65.5
US
Evolent Health Inc
NYSE:EVH
3.1B USD 1.6 -22.1 26.1 277.4
US
Goodrx Holdings Inc
NASDAQ:GDRX
2.8B USD 3.7 -311.1 33.2 -108.4
P/E Multiple
Earnings Growth
US
Castlight Health Inc
NYSE:CSLT
Average P/E: 71.5
Negative Multiple: -38.5 		N/A
US
Veeva Systems Inc
NYSE:VEEV
61.1
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
163.7
119%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -340.1 N/A
JP
M3 Inc
TSE:2413
24.2
26%
US
Doximity Inc
NYSE:DOCS
33
79%
SE
Sectra AB
STO:SECT B
99.5
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -22.1 N/A
US
Goodrx Holdings Inc
NASDAQ:GDRX
Negative Multiple: -311.1 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Castlight Health Inc
NYSE:CSLT
Average EV/EBITDA: 37.9
Negative Multiple: -118.6 		N/A
US
Veeva Systems Inc
NYSE:VEEV
60.9
221%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
AU
Pro Medicus Ltd
ASX:PME
112.5
124%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -179.9 N/A
JP
M3 Inc
TSE:2413
12.6
24%
US
Doximity Inc
NYSE:DOCS
22.1
103%
SE
Sectra AB
STO:SECT B
Negative Multiple: -65.5 N/A
US
Evolent Health Inc
NYSE:EVH
26.1
194%
US
Goodrx Holdings Inc
NASDAQ:GDRX
33.2
305%
EV/EBIT Multiple
EBIT Growth
US
Castlight Health Inc
NYSE:CSLT
Average EV/EBIT: 91.9
Negative Multiple: -30.3 		N/A
US
Veeva Systems Inc
NYSE:VEEV
65.5
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
112.5
110%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -167.2 N/A
JP
M3 Inc
TSE:2413
14.2
N/A
US
Doximity Inc
NYSE:DOCS
23.5
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -65.5 N/A
US
Evolent Health Inc
NYSE:EVH
277.4
2 086%
US
Goodrx Holdings Inc
NASDAQ:GDRX
Negative Multiple: -108.4 N/A

See Also

Summary
CSLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CSLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CSLT stock valuation using valuation multiples.
Wall Street Estimates
CSLT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CSLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.